参考文献/References:
[1] BLENNOW K,LEON M J D,ZETTERBERG H. Alzheimer’s disease[J]. Lancet,2006,368:387-403.
[2]PRINCE M,COMAS-HERRERA A,KNAPP M,et al. World Alzheimer Report 2016:improving healthcare for people with dementia. Coverage,quality and costs now and in the future[R]. London:Alzheimer’s Disease International,2016.
[3]KASA P,RAKONCZAY Z,GULYA K. The cholinergic system in Alzheimer’s disease[J]. Trends in neurosciences,1997,52:511-535.
[4]DVIR H,SILMAN I,ROSENBERRY T L,et al. Acetylcholinesterase:from 3D structure to function[J]. Chemico-biological interactions,2010,187:10-22.
[5]NELSON L,TABET N. Slowing the progression of Alzheimer’s disease; what works?[J]. Ageing research reviews,2015,23:193-209.
[6]LI Y,QIANG X M,LUO L,et al. Multitarget drug design strategy against Alzheimer’s disease:Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties[J]. Bioorganic and medicinal chemistry,2017,25:714-726.
[7]LI Y,QIANG X M,LUO L,et al. Aurone Mannich base derivatives as promising multifunctional agents with acetylcholinesterase inhibition,anti-β-amyloid aggragation and neuroprotective properties for the treatment of Alzheimer’s disease[J]. European journal of medicinal chemistry,2016,126:762-775.
[8]LEMES L F N,DE ANDRADE RAMOS G,DE OLIVEIRA A S,et al. Cardanol-derived AChE inhibitors:towards the development of dual binding derivatives for Alzheimer’s disease[J]. European journal of medicinal chemistry,2016,108:687-700.
[9]FRISCH M J,TRUCKS G W,SCHLEGEL H B,et al. Gaussian 09[Z]. Wallingford:Gaussion Inc.,2009.
[10]MORRIS G M,HUEY R,LINDSTROM W,et al. AutoDock4 and AutoDockTools4:automated docking with selective receptor flexibility[J]. Journal of computational chemistry,2009,30:2785-2791.
[11]JIANG N,MA J. Conformational simulations of aqueous solvated alpha-conotoxin GI and its single disulfide analogues using a polarizable force field model[J]. Journal of physical chemistry A,2008,112(40):9854-9867.
[12]WANG J M,WOLF R M,CALDWELL J W,et al. Development and testing of a general amber force field[J]. Journal of computational chemistry,2004,25:1157-1174.
[13]GENHEDEN S,RYDE U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities[J]. Expert opinion on drug discovery,2015,10:449-461.
[14]RAFI S B,CUI G L,SONG K,et al. Insight through molecular mechanics Poisson-Boltzmann surface area calculations into the binding affinity of triclosan and three analogues for FabI,the E. coli enoyl reductase[J]. Journal of medicinal chemistry,2006,49(15):4574-4580.
[15]WALLACE A C,LASKOWSKI R A,THORNTON J M. Ligplot:a program to generate schematic diagrams of protein-ligand interactions[J]. Protein engineering,1995,8(2):127-134.
相似文献/References:
[1]杨雪雨,王 璇,董珂珂,等.乙酰胆碱酯酶AChE与其抑制剂1,3,4-噻二唑类衍生物的结合机理研究[J].南京师范大学学报(自然科学版),2017,40(02):144.[doi:10.3969/j.issn.1001-4616.2017.02.024]
Yang Xueyu,Wang Xuan,Dong Keke,et al.Investigation of Binding Mechanism Between 1,3,4-ThiadiazolInhibitors and AChE by Molecular Dynamic Simulations[J].Journal of Nanjing Normal University(Natural Science Edition),2017,40(03):144.[doi:10.3969/j.issn.1001-4616.2017.02.024]